Australia markets close in 37 minutes

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.3100+0.1200 (+2.86%)
At close: 04:00PM EDT
4.0250 -0.28 (-6.61%)
After hours: 05:51PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
7,526
5,181
2,509
1,618
23.02
Cost of revenue
227.938
201.879
370.394
328.118
86.712
Gross profit
7,298
4,979
2,138
1,290
-63.692
Operating expenses
Research development
27.205
181.907
300.789
590.476
6,555
Selling general and administrative
13,487
12,228
9,624
8,851
6,429
Total operating expenses
13,514
12,410
9,924
9,442
12,984
Operating income or loss
-6,216
-7,431
-7,786
-8,152
-13,047
Interest expense
501.37
500
500
500.05
112.994
Total other income/expenses net
-
-
-
105.13
-
Income before tax
-6,528
-7,792
-8,224
-8,538
-13,155
Income from continuing operations
-6,528
-7,792
-8,224
-8,538
-13,155
Net income
-6,528
-7,792
-8,224
-8,538
-13,155
Net income available to common shareholders
-6,528
-7,792
-8,224
-8,538
-13,155
Basic EPS
-2.27
-27.96
-31.44
-38.88
-74.88
Diluted EPS
-2.27
-27.96
-31.44
-38.88
-74.88
Basic average shares
3,343
278.589
261.968
223.511
177.028
Diluted average shares
3,343
278.589
261.968
223.511
177.028